This site is intended for Healthcare Professionals only

DHSC extends SSP for Salazopyrin until March 8

Latest bookmark icon off

DHSC extends SSP for Salazopyrin until March 8

The Department of Health and Social Care has extended the serious shortage protocol for Salazopyrin EN-Tabs 500mg until March 8.

The previous SSP for the product ran until January 22 and the PSNC reminded pharmacists to ensure they use “the latest version of an SSP before considering the supply of an alternative product.”

Other active SSPs include Fluoxetine 10mg tablets (March 31), Fluoxetine 30mg capsules (March 12), Fluoxetine 40mg capsules (March 31) and Levothyroxine 12.5mcg tablets (March 5).

The PSNC said reimbursement is for medicines “supplied in accordance with the SSP and not the originally prescribed medicine".

Copy Link Record my learning outcomes
Save for later bookmark icon off


Discover the latest pharmacy news with daily updates and information to keep you in the know.